When the AD group was stratified into MCI‐AD and ADD groups, the CSF TMEM119 concentration was found to be significantly higher in both the MCI‐AD (p = 0.018) and ADD (p = 0.001) groups compared to the control group. This evidence concerns the gene TMEM119 and Alzheimer disease.